Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

Chronic alcoholism treatment disulfiram may contain anxiolytic properties

Staff Writer
Staff Writer 10 months ago
Updated 2022/04/15 at 1:16 AM
Share
SHARE

A treatment often used to treat symptoms associated with alcohol use disorder may also provide efficacy as part of its purported anxiolytic properties.

Disulfiram, used to suppress tendencies associated with chronic alcoholism, is said to inhibit chemokine receptor signaling pathways related to the regulation of anxiety in rodents.

The study was conducted by experts at the Tokyo University of Science. It was released online in Frontiers in Pharmacology.

“This is the first report suggesting that disulfiram produces anxiolytic-like effects in rodents,” the journal report states. “We found that the presynaptic inhibitory effects on glutaminergic neurons in the PL-PFC may be involved in its underlying mechanism.”


“Disulfiram could therefore be an effective and novel anxiolytic drug that does not produce benzodiazepine-related adverse effects, such as amnesia, coordination disorder, or sedation, as found with diazepam,” according to researchers.

The study is one of the first of its kind suggesting that disulfiram may induce anxiolytic effects, prompting new drug development efforts.

Photo: Shutterstock

You Might Also Like

New study explores test that can detect Alzheimer’s years before diagnosis

Prenatal exposure to pollution may be linked to lower cognitive scores in infants

Researchers unveil new drug candidate to help treat adrenoleukodystrophy

New research finds Alzheimer’s risk factors affect males and females very differently

Study establishes critical role in regulating excessive folding of gyri in brain

TAGGED: disulfiram, alcohol use disorder, alcoholism
Staff Writer April 14, 2022
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article New study examines the association between exercise and depressive disorders
Next Article Nearly one-third of breast cancer patients experience depressive symptoms

Recommended

Clinical

New study explores test that can detect Alzheimer’s years before diagnosis

1 Min Read
Clinical

Prenatal exposure to pollution may be linked to lower cognitive scores in infants

1 Min Read
Clinical

Researchers unveil new drug candidate to help treat adrenoleukodystrophy

1 Min Read
Clinical

New research finds Alzheimer’s risk factors affect males and females very differently

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?